Customize this page
|
2
Votes
vote
GenVec receives FDA orphan drug designation for TNFeradeGenVec, Inc. announced today that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to TNFerade(TM) for the treatment of pancreatic cancer. ... |
|
2
Votes
vote
What's in a Name: Understanding the Classifications of Bottled WaterThere has been a proliferation of bottled waters on store shelves and in restaurants. There are differences, whether you can taste them or not, and the industry is tightly regulated by both the FDA (U.S. Food and Drug Administration) and the IBWA (International Bottled Water Association). The F... |
|
0
Votes
vote
United States Environmental Protection Agency bans Carbofuran pesticide usageThe American farmers who will use carbofuran pesticide to treat their crops come December 31 will be prosecuted by the United States Food and Drug Administration. According to the US Environmental Protection Agency (EPA) Office of Prevention, Pesticides and Toxic Substances carbofuran doesn&rsquo... |
|
0
Votes
vote
CryoLife granted FDA approval for BioFoam human clinical trialCryoLife, Inc., an implantable biological medical device and cardiovascular tissue processing company, today announced that the U.S. Food and Drug Administration (FDA) has granted approval for the company's Investigational Device Exemption (IDE) to conduct a human clinical trial for its BioFoam&r... |
|
0
Votes
vote
FDA files complaint against sandwich manufacturer; company allegedly failed to correct violationsThe U.S. Department of Justice, on behalf of the U.S. Food and Drug Administration, has filed a complaint for permanent injunction against Rel's Foods Inc. (Rel's), of Oakland, Calif., seeking to stop the company from manufacturing, producing, and selling adulterated food products. ... |
|
0
Votes
vote
Theratechnologies Presents Clinically Relevant Improvements in Patient Reported Outcome Parameters at the International Workshop on Adverse Drug Reactions and Co-Morbidities in HIVMONTREAL, CANADA--(Marketwire - Oct. 26, 2009) - Theratechnologies (TSX:TH) announced today that additional patient reported outcome results from a combined analysis from both Phase 3 clinical trials evaluating tesamorelin in the treatment of excess abdominal fat in HIV-infected patients with lip... |
Create tab
Block this tag
american-farmers
angelini
antigen
bad-cholesterol
bottled-water-association
chinese-state
environmental-protection-agency
familial-hypercholesterolemia
fda-approval
flares
flu
flu-vaccine
flu-vaccines
flu-virus
food-and-drug
food-and-drug-administration-fda
food-safety-standards
heart-failure
hiv-prevention
lower-cholesterol
oakland-calif
orphan-drug-designation
relaxin
school-of-public-health
search-field
state-food
swine-flu
taste-buds
today-announced-that
u-s-department
united-states
us-food-and-drug-administration
